Non-Polio Enterovirus Inhibitors: Scaffolds, Targets, and Potency─What’s New?

Hugo Fernando Georges Roux, Franck Touret, Pascal Rathelot, Pietro Sciò, Antonio Coluccia, Patrice Vanelle and Manon Roche

ACS Infect. Dis., 2025, 11, 21
DOI: 10.1021/acsinfecdis.4c00606

Targeting PI4KB and Src/Abl host kinases as broad-spectrum antiviral strategy: Myth or real opportunity?

Maria Grazia Martina, Daniele Rubini, Marco Radi and Valeria Cagno

Antiviral Research, 2025, 235, 106100
DOI: 10.1016/j.antiviral.2025.106100

Identification of 4′-Thiouridine as an Orally Available Antiviral Agent Targeting Both RdRp and NiRAN Functions of SARS-CoV-2 Nsp12

Minjae Kim, Myoung Kyu Lee, Inseong Jo, Yejin Jang, Soo Bong Han, Juyeon Lee, Ayeon Yang, Dnyandev B. Jarhad, Hongseok Choi, Yuhei Nogi, Noriko Saito-Tarashima, Noriaki Minakawa, Meehyein Kim and Lak Shin Jeong

J. Med. Chem., 2025, 68, 12414
DOI: 10.1021/acs.jmedchem.4c02874

7-Amino-3-phenyl-2-methyl-pyrazolopyrimidine derivatives inhibit human rhinovirus replication

Prashant Chakrasali, Dasom Hwang, Joo-Youn Lee, Eunhye Jung, Hye Lim Lee, Alba Reneesh, Adam Skarka, Kamil Musilek, Nhung Hong Nguyen, Jin Soo Shin and Young-Sik Jung

European Journal of Medicinal Chemistry, 2024, 276, 116690
DOI: 10.1016/j.ejmech.2024.116690